PMID: 18717509Aug 23, 2008Paper

Epidemiology of opioid pharmacy claims in the United States

Journal of Opioid Management
Rachel E WilliamsStephen W Janning

Abstract

To describe opioid pharmacy claims patterns in the United States among an insured population. Information was obtained from the US insurance claims database, IMS Lifelink, between 1997 and 2002. Descriptive statistics of opioid claims patterns were described with stratification by gender, age, and year of use. The prevalence of insured people with opioid claims increased from 17.1 percent in 1997 to 18.4 percent in 2002. Among people with an opioid claim, 24 percent had > or =30 days and 10 percent had > or =90 days of days supplied based on the insurance claims. Prevalence varied by type of opioid; 56 percent of people with a claim received propoxyphene, 43 percent received codeine, 23 percent received oxycodone, and 17 percent received hydrocodone. Sustained-release opioids were found among 6 percent of those with a claim. With respect to the dose of opioids in the pharmacy claims (expressed as morphine equivalent total daily dose), 71 percent had claims for <50 mg, 55 percent had claims for 50-99 mg, and 24 percent had claims for > or =100 mg. Women, individuals with cancer, and older patients had significantly more pharmacy claims as well as claims for higher doses of opioids (p < 0.05). Internal medicine and family practic...Continue Reading

Citations

Dec 17, 2009·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Stephen M ThielkeMark D Sullivan
Oct 27, 2011·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Leonard J PaulozziLarry D Loring
Jun 16, 2010·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Nabarun DasguptaRichard C Dart
Sep 1, 2009·Pharmacoepidemiology and Drug Safety·Denise BoudreauConstance Weisner
Jan 13, 2011·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Beth Darnall, Hong Li
Aug 22, 2012·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Beth D DarnallRoger Chou
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Meredith NobleKaren M Schoelles
Nov 13, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Ahraaz WyneRita S Suri
Nov 19, 2011·Journal of the American Geriatrics Society·Sascha DublinLisa A Jackson
Oct 18, 2014·Journal of Addiction Medicine·Jeanne ManubayMaria Sullivan
Aug 21, 2015·Journal of the American Geriatrics Society·Sascha DublinEric B Larson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.